{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:19:51Z","timestamp":1732040391648},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.compbiomed.2021.104359","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T17:31:46Z","timestamp":1617125506000},"page":"104359","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"special_numbering":"C","title":["Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning"],"prefix":"10.1016","volume":"133","author":[{"given":"Onat","family":"Kadioglu","sequence":"first","affiliation":[]},{"given":"Mohamed","family":"Saeed","sequence":"additional","affiliation":[]},{"given":"Henry Johannes","family":"Greten","sequence":"additional","affiliation":[]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2021.104359_bib1","series-title":"Situation Reports","year":"2020"},{"key":"10.1016\/j.compbiomed.2021.104359_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2021.104359_bib3","series-title":"Discovery of a Novel Coronavirus Associated with the Recent Pneumonia Outbreak in Humans and its Potential Bat Origin","author":"Zhou","year":"2020"},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104359_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbrc.2020.02.071","article-title":"Structure analysis of the receptor binding of 2019-nCoV","volume":"525","author":"Chen","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.compbiomed.2021.104359_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/v11110979","article-title":"Viral metagenomics revealed Sendai virus and coronavirus infection of Malayan pangolins (Manis javanica)","volume":"11","author":"Liu","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.compbiomed.2021.104359_bib6","doi-asserted-by":"crossref","first-page":"104212","DOI":"10.1016\/j.meegid.2020.104212","article-title":"Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event","volume":"79","author":"Paraskevis","year":"2020","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.compbiomed.2021.104359_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/bs.aivir.2018.01.001","article-title":"Hosts and sources of endemic human coronaviruses","volume":"100","author":"Corman","year":"2018","journal-title":"Adv. Virus Res."},{"issue":"11","key":"10.1016\/j.compbiomed.2021.104359_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104359_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5582\/bst.2020.01030","article-title":"Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment","volume":"14","author":"Wang","year":"2020","journal-title":"Bioscience Trends"},{"issue":"12","key":"10.1016\/j.compbiomed.2021.104359_bib10","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.compbiomed.2021.104359_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00134-020-05943-5","article-title":"Critical care management of adults with community-acquired severe respiratory viral infection","volume":"46","author":"Arabi","year":"2020","journal-title":"Intensive Care Med."},{"issue":"6","key":"10.1016\/j.compbiomed.2021.104359_bib12","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.3346\/jkms.2020.35.e79","article-title":"Case of the index patient who caused tertiary transmission of COVID-19 infection in Korea: the application of lopinavir\/ritonavir for the treatment of COVID-19 infected pneumonia monitored by quantitative RT-PCR","volume":"35","author":"Lim","year":"2020","journal-title":"J. Korean Med. Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104359_bib13","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1186\/s13063-020-04576-9","volume":"21","author":"Denholm","year":"2020","journal-title":"Trials"},{"issue":"11","key":"10.1016\/j.compbiomed.2021.104359_bib14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jama.2020.16349","article-title":"Effect of remdesivir vs standard care on clinical status at 11 days in patients with moderate COVID-19: a randomized clinical trial","volume":"324","author":"Spinner","year":"2020","journal-title":"J. Am. Med. Assoc."},{"issue":"5","key":"10.1016\/j.compbiomed.2021.104359_bib15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12630-020-01591-x","article-title":"Practical recommendations for critical care and anesthesiology teams caring for novel coronavirus (2019-nCoV) patients","volume":"67","author":"Wax","year":"2020","journal-title":"Can. J. Anaesthesiol."},{"issue":"8","key":"10.1016\/j.compbiomed.2021.104359_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.compbiomed.2021.104359_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"3","key":"10.1016\/j.compbiomed.2021.104359_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1021\/np200906s","article-title":"Natural products as sources of new drugs over the 30 years from 1981 to 2010","volume":"75","author":"Newman","year":"2012","journal-title":"J. Nat. Prod."},{"issue":"12","key":"10.1016\/j.compbiomed.2021.104359_bib19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1517\/17460441.2015.1083006","article-title":"Quantitative structure-activity relationship: promising advances in drug discovery platforms","volume":"10","author":"Wang","year":"2015","journal-title":"Expet Opin. Drug Discov."},{"issue":"18","key":"10.1016\/j.compbiomed.2021.104359_bib20","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","article-title":"Concepts of artificial intelligence for computer-assisted drug discovery","volume":"119","author":"Yang","year":"2019","journal-title":"Chem. Rev."},{"issue":"10","key":"10.1016\/j.compbiomed.2021.104359_bib21","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/cells8101286","article-title":"A machine learning-based prediction platform for P-glycoprotein modulators and its validation by molecular docking","volume":"8","author":"Kadioglu","year":"2019","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.compbiomed.2021.104359_bib22","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s10822-019-00274-0","article-title":"Validating the validation: reanalyzing a large-scale comparison of deep learning and machine learning models for bioactivity prediction","volume":"34","author":"Robinson","year":"2020","journal-title":"J. Comput. Aided Mol. Des."},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104359_bib23","doi-asserted-by":"crossref","first-page":"8857","DOI":"10.1038\/s41598-018-27214-6","article-title":"Cancer Drug Response Profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature","volume":"8","author":"Chang","year":"2018","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.compbiomed.2021.104359_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002294","article-title":"Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2 '-O-methylation by nsp16\/nsp10 protein complex","volume":"7","author":"Chen","year":"2011","journal-title":"PLoS Pathog."},{"issue":"16","key":"10.1016\/j.compbiomed.2021.104359_bib25","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1128\/JVI.00058-12","article-title":"Characterization of a viral phosphoprotein binding site on the surface of the respiratory syncytial nucleoprotein","volume":"86","author":"Galloux","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.compbiomed.2021.104359_bib26","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104359_bib27","first-page":"1","article-title":"Drug resistance of human immunodeficiency virus and overcoming it by natural products","volume":"23","author":"Hupfeld","year":"2009","journal-title":"In Vivo"},{"issue":"4","key":"10.1016\/j.compbiomed.2021.104359_bib28","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/13892002113149990095","article-title":"Polyphenols: a diverse class of multi-target anti-HIV-1 agents","volume":"14","author":"Andrae-Marobela","year":"2013","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.compbiomed.2021.104359_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jep.2017.08.005","article-title":"Anti-HIV activity of southern African plants: current developments, phytochemistry and future research","volume":"210","author":"Prinsloo","year":"2018","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.compbiomed.2021.104359_bib30","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/ijms19051459","article-title":"Medicinal plants used in the treatment of human immunodeficiency virus","volume":"19","author":"Salehi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.compbiomed.2021.104359_bib31","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1021\/ci600289v","article-title":"Virtual screening of Chinese herbs with random forest","volume":"47","author":"Ehrman","year":"2007","journal-title":"J. Chem. Inform. Model."},{"issue":"4","key":"10.1016\/j.compbiomed.2021.104359_bib32","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10637-016-0339-6","article-title":"Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells","volume":"34","author":"Kadioglu","year":"2016","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.compbiomed.2021.104359_bib33","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bcp.2016.01.014","article-title":"Interactions of human P-glycoprotein transport substrates and inhibitors at the drug binding domain: functional and molecular docking analyses","volume":"104","author":"Kadioglu","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.compbiomed.2021.104359_bib34","unstructured":"China trials anti-HIV drug on coronavirus patients. https:\/\/www.theguardian.com\/world\/2020\/feb\/07\/china-trials-anti-hiv-drug-coronavirus-patients. (accessed February 13, 2020)."},{"key":"10.1016\/j.compbiomed.2021.104359_bib35","series-title":"How Experts Plan to Treat the New Coronavirus","author":"Saplakoglu","year":"2020"},{"key":"10.1016\/j.compbiomed.2021.104359_bib36","article-title":"Can an anti-HIV combination or other existing drugs outwit the new coronavirus?","author":"Cohen","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2021.104359_bib37","series-title":"Flu and HIV Drugs Show Efficacy against Coronavirus","author":"Offord","year":"2020"},{"issue":"7","key":"10.1016\/j.compbiomed.2021.104359_bib38","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.1021\/acs.jctc.0c00121","article-title":"Extending the applicability of the ANI deep learning molecular potential to sulfur and halogens","volume":"16","author":"Devereux","year":"2020","journal-title":"J. Chem. Theor. Comput."},{"issue":"24","key":"10.1016\/j.compbiomed.2021.104359_bib39","doi-asserted-by":"crossref","first-page":"241733","DOI":"10.1063\/1.5023802","article-title":"Less is more: sampling chemical space with active learning","volume":"148","author":"Smith","year":"2018","journal-title":"J. Chem. Phys."},{"issue":"7","key":"10.1016\/j.compbiomed.2021.104359_bib40","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1021\/acs.jcim.7b00190","article-title":"PlayMolecule ProteinPrepare: a web application for protein preparation for molecular dynamics simulations","volume":"57","author":"Martinez-Rosell","year":"2017","journal-title":"J. Chem. Inform. Model."},{"issue":"4","key":"10.1016\/j.compbiomed.2021.104359_bib41","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1021\/acs.jctc.6b00049","article-title":"HTMD: high-throughput molecular dynamics for molecular discovery","volume":"12","author":"Doerr","year":"2016","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.compbiomed.2021.104359_bib42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.virol.2019.08.031","article-title":"Coronavirus genomic RNA packaging","volume":"537","author":"Masters","year":"2019","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.compbiomed.2021.104359_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/14728222.2017.1271415","article-title":"MERS-CoV spike protein: a key target for antivirals","volume":"21","author":"Du","year":"2017","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104359_bib44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3390\/v11010060","article-title":"Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain","volume":"11","author":"Zhou","year":"2019","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.compbiomed.2021.104359_bib45","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.3390\/v6082991","article-title":"The coronavirus nucleocapsid is a multifunctional protein","volume":"6","author":"McBride","year":"2014","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.compbiomed.2021.104359_bib46","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.drudis.2015.11.015","article-title":"Recent insights into the development of therapeutics against coronavirus diseases by targeting N protein","volume":"21","author":"Chang","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"21","key":"10.1016\/j.compbiomed.2021.104359_bib47","doi-asserted-by":"crossref","first-page":"10900","DOI":"10.1128\/JVI.00385-06","article-title":"Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis","volume":"80","author":"Almazan","year":"2006","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.compbiomed.2021.104359_bib48","first-page":"5193","article-title":"Editorial - sofosbuvir\/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents","volume":"24","author":"Izzi","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.compbiomed.2021.104359_bib49","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/jmv.24736","article-title":"Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses","volume":"89","author":"Elfiky","year":"2017","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.compbiomed.2021.104359_bib50","first-page":"1","article-title":"Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase","author":"Khan","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2021.104359_bib51","first-page":"1","article-title":"Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with M(pro)","author":"J","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104359_bib52","doi-asserted-by":"crossref","first-page":"19125","DOI":"10.1038\/s41598-020-75762-7","article-title":"Searching for target-specific and multi-targeting organics for Covid-19 in the Drugbank database with a double scoring approach","volume":"10","author":"Murugan","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2021.104359_bib53","first-page":"1","article-title":"The potential role of procyanidin as a therapeutic agent against SARS-CoV-2: a text mining, molecular docking and molecular dynamics simulation approach","author":"Maroli","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104359_bib54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/138945011793591626","article-title":"Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy","volume":"12","author":"Efferth","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.compbiomed.2021.104359_bib55","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.phrs.2016.02.017","article-title":"Antischistosomal activity of artemisinin derivatives in vivo and in patients","volume":"110","author":"Saeed","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.compbiomed.2021.104359_bib56","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin. Canc. Biol."},{"issue":"6","key":"10.1016\/j.compbiomed.2021.104359_bib57","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.biotechadv.2018.01.001","article-title":"Beyond malaria: the inhibition of viruses by artemisinin-type compounds","volume":"36","author":"Efferth","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.compbiomed.2021.104359_bib58","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.phymed.2018.06.002","article-title":"The activity of Artemisia spp. and their constituents against Trypanosomiasis","volume":"47","author":"Nass","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.compbiomed.2021.104359_bib59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/5584_2019_428","article-title":"Quinolines and quinolones as antibacterial, antifungal,anti-virulence, antiviral and anti-parasitic agents","volume":"1282","author":"Senerovic","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"issue":"22","key":"10.1016\/j.compbiomed.2021.104359_bib60","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1016\/j.bmc.2010.09.035","article-title":"Bioflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition","volume":"18","author":"Ryu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.compbiomed.2021.104359_bib61","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s10529-011-0845-8","article-title":"Flavonoid-mediated inhibition of SARS coronavirus 3C-like protease expressed in Pichia pastoris","volume":"34","author":"Nguyen","year":"2012","journal-title":"Biotechnol. Lett."},{"issue":"1","key":"10.1016\/j.compbiomed.2021.104359_bib62","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bmc.2013.11.041","article-title":"Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings","volume":"22","author":"Lee","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"12","key":"10.1016\/j.compbiomed.2021.104359_bib63","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.3390\/v7122963","article-title":"Potential broad spectrum inhibitors of the coronavirus 3CLpro: a virtual screening and structure-based drug design study","volume":"7","author":"Berry","year":"2015","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.compbiomed.2021.104359_bib64","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/jmv.24736","article-title":"Quantitative structure-activity relationship and molecular docking revealed a potency of anti-hepatitis C virus drugs against human corona viruses","volume":"89","author":"Elfiky","year":"2017","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.compbiomed.2021.104359_bib65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2478\/acph-2020-0024","article-title":"Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors","volume":"70","author":"Zaher","year":"2020","journal-title":"Acta Pharm."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482521001530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482521001530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T08:52:17Z","timestamp":1706086337000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482521001530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":65,"alternative-id":["S0010482521001530"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104359","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of novel compounds against three targets of SARS CoV-2 coronavirus by combined virtual screening and supervised machine learning","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2021.104359","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104359"}}